Chonluten is a synthetic tripeptide classified as a peptide bioregulator. It is studied for its ability to influence gene expression, potentially regulating cellular processes such as apoptosis and supporting tissue homeostasis, especially in respiratory and epithelial tissues
Chonluten 20 MG
$60.00
Chonluten is a synthetic peptide derivative structurally designed for research purposes in cartilage and joint health. It has been developed as a stabilized analog and is primarily studied in laboratory settings for its potential effects on cartilage regeneration, anti-inflammatory responses, and peptide pharmacology. Preclinical studies have investigated Chonluten in relation to experimental models of osteoarthritis, cartilage degeneration, and joint inflammation.
Research involving Chonluten commonly explores:
• Its role in promoting chondrocyte proliferation and synthesis of extracellular matrix components in cellular and animal models.
• Possible contributions to reducing cartilage breakdown and inflammation in osteoarthritic and joint injury models.
• Experimental modulation of inflammatory cytokines and signaling pathways related to joint disease.
• Its activity in studies of cartilage repair, pain relief, and joint function improvement, where its peptide structure and stability are topics of interest.
Chonluten is provided as a lyophilized powder for laboratory research use only (RUO). It is not intended for diagnostic, therapeutic, or clinical applications and must not be used in humans or animals.
Product details:
• Synonyms: Chonluten peptide
• Purity: ≥98%
• CAS Number: not registered or unavailable
• Molecular Formula: not available
• Molecular Weight: not available
• Appearance: White to off-white lyophilized powder
This product is intended exclusively for scientific research and laboratory investigation in compliance with applicable regulatory guidelines.
In stock
